- Home
- TSAT vs BWAY Comparison
TSAT vs BWAY Comparison
Compare TSAT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- BWAY
- Stock Information
- Founded
- TSAT 1969
- BWAY 2003
- Country
- TSAT Canada
- BWAY Israel
- Employees
- TSAT 490
- BWAY N/A
- Industry
- TSAT Metal Fabrications
- BWAY Medical/Dental Instruments
- Sector
- TSAT Industrials
- BWAY Health Care
- Exchange
- TSAT Nasdaq
- BWAY Nasdaq
- Market Cap
- TSAT 164.6M
- BWAY 159.3M
- IPO Year
- TSAT 1996
- BWAY 2019
- Fundamental
- Price
- TSAT $11.70
- BWAY $9.80
- Analyst Decision
- TSAT Hold
- BWAY Strong Buy
- Analyst Count
- TSAT 1
- BWAY 3
- Target Price
- TSAT $9.00
- BWAY $13.17
- AVG Volume (30 Days)
- TSAT 50.0K
- BWAY 88.5K
- Earning Date
- TSAT 11-14-2024
- BWAY 11-12-2024
- Dividend Yield
- TSAT N/A
- BWAY N/A
- EPS Growth
- TSAT N/A
- BWAY N/A
- EPS
- TSAT 2.55
- BWAY 0.04
- Revenue
- TSAT $450,756,875.00
- BWAY $38,631,000.00
- Revenue This Year
- TSAT N/A
- BWAY $378.91
- Revenue Next Year
- TSAT N/A
- BWAY $20.27
- P/E Ratio
- TSAT $4.28
- BWAY $122.14
- Revenue Growth
- TSAT N/A
- BWAY 34.19
- 52 Week Low
- TSAT $6.93
- BWAY $4.61
- 52 Week High
- TSAT $15.02
- BWAY $10.98
- Technical
- Relative Strength Index (RSI)
- TSAT 45.72
- BWAY 47.15
- Support Level
- TSAT $10.11
- BWAY $8.96
- Resistance Level
- TSAT $13.83
- BWAY $10.27
- Average True Range (ATR)
- TSAT 0.94
- BWAY 0.61
- MACD
- TSAT -0.11
- BWAY -0.09
- Stochastic Oscillator
- TSAT 43.01
- BWAY 37.39
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a global satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.